Exagen Inc. Reports Strong Third Quarter 2023 Results
13.11.2023 - SAN DIEGO, California, Nov. 13, 2023 (GLOBE NEWSWIRE) - Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2023. Recognized total revenue of $13.4 ...